Leaderboard

En | De
No articles selected!     View Cart  
You are here: Gynecology » Breast Diseases 17. November 2026
Search
medline.ch
Breast Diseases
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Reproduction
Genital Diseases female
Infertility
Breast Diseases
Menopause
Pregnancy
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 11216  Previews Next
   
   Articles 1 - 20 / 224303  
   
Residual Pure Intralymphatic Breast Carcinoma After Neoadjuvant Therapy: Clinicopathologic Analysis and Comparative Outcomes Across Published Studies.
Arch Pathol Lab Med
Bahmad HF, Brachtel EF, Jorda M, Gomez-Fernández C, Tjendra Y.
PMID: 43042959 [PubMed - as supplied by publisher]


RE: SHBG as a breast cancer risk biomarker in premenopausal women? Results from an individual patient's pooled analysis and a meta-analysis.
J Natl Cancer Inst
Mokbel K, Mokbel K.
PMID: 43042713 [PubMed - as supplied by publisher]


Dual-target CAR-T cells in triple-negative breast cancer: recent advances and translational challenges.
Front Med (Lausanne)
Su J, Wang B, Xiao H, Zhang Y.
PMID: 43042313 [PubMed]


Regulation and Tumor-Promoting Functions of PD-L1 in Breast Cancer: Mechanisms, Tumor Microenvironment, and Therapeutic Implications.
Breast Cancer (Dove Med Press)
Xiang Y, Wu TW, Gao Y, Chen WQ, Lu ZX.
PMID: 43042303 [PubMed]


Cutaneous and Breast Apocrine Carcinoma: A Diagnostic Dilemma Between Two Mimicking Malignancies Particularly in Axillary Tumors.
World J Oncol
Kawashima K, Matsushita R, Elsaedy EA, Oshi M, Yamada A, Narui K, Khoury T, Ishikawa T, Endo I, Takabe K.
PMID: 43042183 [PubMed]


Real-world performance of a Food and Drug Administration-approved artificial intelligence tool for mammography in patients with prior breast surgery or indwelling biopsy clips.
Radiol Adv
Ambinder EB, Paulbeck C, Zinzuwadia S, Mullen L, Myers KS, Oluyemi E, Panigrahi B.
PMID: 43042179 [PubMed]


Impact of immersive virtual reality combined with lifestyle modification on upper limb function, pain intensity, and range of motion in post-surgical breast cancer survivors: A randomized controlled trial.
Pak J Med Sci
Irshad A, Babur MN, Umar M, Sultana B.
PMID: 43042128 [PubMed]


Correction: Determinants of self-reported sustained breast cancer screening among women in Shenzhen, China: a study based on the health belief model.
Front Public Health
Jin S, Ma X, Yang X, Zhang W, Li H, Gu Y, Wu B.
PMID: 43042028 [PubMed - in process]


Targeting the PI3K/AKT/mTOR pathway in endocrine-resistant, hormone receptor-positive, HER2-negative, advanced breast cancer.
EClinicalMedicine
Glaviano A, Abelman RO, Varkaris A, Varma S, McCann KE, Kumar AP, Diana P, de Bruin RAM, Juric D, Vasan N, Wander SA.
PMID: 43042018 [PubMed]


Efficacy of adding neoadjuvant pembrolizumab to standard chemotherapy for triple-negative breast cancer: A systematic review and meta-analysis of real-world studies.
Pak J Med Sci
Qian X, Ruan L.
PMID: 43041967 [PubMed]


Neoadjuvant systemic therapy and the evolution of axillary management in breast cancer: a mini review and future directions.
Front Oncol
Lohita Krishna K, B S S.
PMID: 43041905 [PubMed]


Set-up accuracy in megavoltage computed tomography-guided adjuvant breast radiotherapy: An analysis of differences between automatic registration and human observers.
North Clin Istanb
Tepetam H, Dursun CU, Nasir Can SS, Hanilce MM, Gunalp G, Gedik D, Karabulut Gul S.
PMID: 43041767 [PubMed]


Effects of exercise interventions on cancer-related fatigue and quality of life in patients with metastatic breast cancer: a systematic review and meta-analysis.
Front Oncol
Zhou M, Zou L, Sun Z, Guo J.
PMID: 43041484 [PubMed]


Ocular adverse event profiles associated with endocrine therapies for breast cancer: a global pharmacovigilance study using FAERS and VigiAccess.
Front Oncol
Wang X, Zuo W, Zhang C, Liu B, Zhu B.
PMID: 43041374 [PubMed]


Peripheral absolute lymphocyte count and survival of patients with triple-negative breast cancer: a meta-analysis.
Front Oncol
Yang H, Ye C, Qin T, Lei Z, Rong Q, Zhou Y, Xie S, Lian B.
PMID: 43041327 [PubMed]


Comparative efficacy and safety of nonhormonal prescription drugs for vasomotor symptoms in women with breast cancer: a systematic review and network meta-analysis.
Front Pharmacol
Liao YS, Deng YP, Song JL, Yu X, Li Q, Lu B, Chen GY.
PMID: 43041301 [PubMed]


Investigation of the ABO gene as a biomarker in breast invasive carcinoma using cancer profiling and blood type distribution.
Front Oncol
Meng W, He J, Du D, Zhang J, Hao Q, Bao Y.
PMID: 43041272 [PubMed]


Association Between Cancer Stage and Parenting Self-Efficacy in Breast Cancer Survivors: A Survey of a Triple-Negative Breast Cancer Community.
J Korean Med Sci
Ahn SY, Kim S, Kimm H, Park E, Lee H, Han E.
PMID: 43041109 [PubMed - indexed for MEDLINE]


Sentinel Lymph Node Biopsy in Post-Neoadjuvant Chemotherapy Breast Cancer Patients Using a Combination of Fluorescein and Blue Dye Versus Blue Dye Alone: Randomized Pilot Feasibility Trial.
World J Surg
Rajendar B, Vishnoi JR, Sharma N, Poonia DR, Yadav R, Yadav T, Elhence P, Pareek P, Misra S.
PMID: 43040966 [PubMed - as supplied by publisher]


Breast carcinogenesis as an organising principle for diagnosis and precision therapy.
Histopathology
Rakha E, Altrabulsi B, Sidlauskas K, Jones LJ, Bockstal MVR.
PMID: 43040850 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 224303    Page 1 of 11216  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1